Visual detection of HPV16 using a photoactivatable CRISPR–Cas12 system

HPV screening is critical for the diagnosis of cervical cancer. This study combines photoactivated CRISPR-Cas12a with a tube-in-tube structure and RPA for rapid HPV16 detection, using blue UV light at 302 nm for portable, on-site diagnostics.